| Pharmaceutical active ingredients: |
| Neostigmine Methylsulfate |
| Available forms, composition and doses of Glycostigmin: |
| N / A |
| Glycostigmin medical category: |
| Human:Neuromuscular disorder drugsParasympathomemetic (cholinergic) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N07AA01 - NeostigmineS01EB06 - Neostigmine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Leiras |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Tilstigmin | Neostigmine Bromide; Neostigmine Methylsulfate | Tablets India |
| Normastigmin mit Pilocarpin | Neostigmine Bromide; Pilocarpine Hydrochloride | Sigmapharm Arzneimittel |
| Pilostigmin Puroptal | Neostigmine Bromide; Pilocarpine Hydrochloride | Metochem-Pharma |
| Syncarpin-N | Neostigmine Bromide; Pilocarpine Hydrochloride | Dr. Winzer Pharma |
| Beemine | Neostigmine Methylsulfate | Biomiicron Pharmaceuticals |
| Intrastigmina | Neostigmine Methylsulfate | Istituto Luso Farmaco d'Italia |
| Myostigmin | Neostigmine Methylsulfate | Neon Laboratories |
| Neostig | Neostigmine Methylsulfate | Carinopharm |
| Neostigmina | Neostigmine Methylsulfate | Biosano Laboratorios |
| Neostigmina | Neostigmine Methylsulfate | Sanderson Laboratorio |